Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Equity (2016 - 2025)

Haemonetics (HAE) has 16 years of Return on Equity data on record, last reported at 0.2% in Q4 2025.

  • For Q4 2025, Return on Equity rose 5.0% year-over-year to 0.2%; the TTM value through Dec 2025 reached 0.2%, up 5.0%, while the annual FY2025 figure was 0.19%, 6.0% up from the prior year.
  • Return on Equity reached 0.2% in Q4 2025 per HAE's latest filing, up from 0.19% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.2% in Q4 2025 and bottomed at 0.03% in Q1 2022.
  • Average Return on Equity over 5 years is 0.13%, with a median of 0.13% recorded in 2022.
  • Peak YoY movement for Return on Equity: fell -12bps in 2021, then rose 10bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.05% in 2021, then surged by 180bps to 0.13% in 2022, then rose by 8bps to 0.14% in 2023, then increased by 6bps to 0.15% in 2024, then surged by 37bps to 0.2% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.2% in Q4 2025, 0.19% in Q3 2025, and 0.19% in Q2 2025.